DK1954251T3 - Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf - Google Patents

Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf

Info

Publication number: DK1954251T3
Authority: DK; Denmark
Prior art keywords: release; preparation; long; active ingredient; iron salt
Prior art date: 2005-12-01

Application number

DK06831163.8T

Other languages

English (en)

Inventor

Didier Berthoumieu

Pierre Dupinay

Philippe Trannoy

Original Assignee

Pf Medicament

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-01

Filing date

2006-11-23

Publication date

2012-07-02

2006-11-23 Application filed by Pf Medicament filed Critical Pf Medicament

2012-07-02 Application granted granted Critical

2012-07-02 Publication of DK1954251T3 publication Critical patent/DK1954251T3/da

Links

239000004480 active ingredient Substances 0.000 title 1
150000002505 iron Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK06831163.8T 2005-12-01 2006-11-23 Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf DK1954251T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0512189A FR2894143B1 (fr)	2005-12-01	2005-12-01	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
PCT/FR2006/002577 WO2007063200A1 (fr)	2005-12-01	2006-11-23	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation

Publications (1)

Publication Number	Publication Date
DK1954251T3 true DK1954251T3 (da)	2012-07-02

Family

ID=36968738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06831163.8T DK1954251T3 (da)	2005-12-01	2006-11-23	Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf

Country Status (27)

Country	Link
US (1)	US8834923B2 (da)
EP (1)	EP1954251B1 (da)
JP (1)	JP5674275B2 (da)
KR (1)	KR101332744B1 (da)
CN (1)	CN101321520A (da)
AR (1)	AR057212A1 (da)
AT (1)	ATE548030T1 (da)
AU (1)	AU2006319077B2 (da)
BR (1)	BRPI0619774B1 (da)
CA (1)	CA2632547C (da)
DK (1)	DK1954251T3 (da)
ES (1)	ES2383760T3 (da)
FR (1)	FR2894143B1 (da)
IL (1)	IL191758A (da)
MA (1)	MA29770B1 (da)
NO (1)	NO339720B1 (da)
NZ (1)	NZ566783A (da)
PL (1)	PL1954251T3 (da)
PT (1)	PT1954251E (da)
RS (1)	RS52308B (da)
RU (1)	RU2414211C2 (da)
SI (1)	SI1954251T1 (da)
TN (1)	TNSN08152A1 (da)
TW (1)	TWI374035B (da)
UA (1)	UA93530C2 (da)
WO (1)	WO2007063200A1 (da)
ZA (1)	ZA200801896B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0613583D0 (en) *	2006-07-05	2006-08-16	Sericol Ltd	A printing ink
CN101912049A (zh) *	2010-07-27	2010-12-15	广州市正百饲料科技有限公司	包被微量元素预混料及其制备方法
CN103191078B (zh) *	2012-01-06	2018-01-09	常州善美药物研究开发中心有限公司	一种双膜多药层的高溶解度盐类药物控释片
NL2014348B1 (en)	2015-02-25	2016-10-13	Univ Delft Tech	Controlled release from particles encapsulated by molecular layer deposition.
RU2702690C2 (ru) *	2015-08-13	2019-10-09	БИОЛИНГУС АйПи ЛЛСи	Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
RU2616264C1 (ru) *	2016-03-28	2017-04-13	Санкт-Петербургское Государственное бюджетное учреждение здравоохранения "Родильный дом N 10"	Способ профилактики железодефицитной анемии у несовершеннолетних беременных женщин
RU2623071C1 (ru) *	2016-09-29	2017-06-21	федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет"	Лечебно-профилактический хелатный железосодержащий препарат для сельскохозяйственных животных
CN106344534B (zh) *	2016-09-30	2019-07-19	广西科技大学	硫酸亚铁肠溶滴丸的制备方法
US20200275685A1 (en) *	2017-11-14	2020-09-03	PIZETA PHARMA S.p.A.	Oral administration form comprising an iron-copper mixture and its use as a food supplement
CN109999058A (zh) *	2019-05-22	2019-07-12	江阴天江药业有限公司	一种胶类中药的烊化方法和产品，以及由该产品制得的固体饮料及其制备方法
US20250319027A1 (en) *	2022-07-01	2025-10-16	Vitakey Inc.	Nutraceutical particles

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3622487A1 (de) *	1986-07-02	1988-01-14	Schering Ag	Arzneimittel mit verzoegerter wirkstoffabgabe
IE82916B1 (en) *	1990-11-02	2003-06-11	Elan Corp Plc	Formulations and their use in the treatment of neurological diseases
US5478577A (en)	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5286493A (en) *	1992-01-27	1994-02-15	Euroceltique, S.A.	Stabilized controlled release formulations having acrylic polymer coating
DE4332394A1 (de) *	1993-09-23	1995-03-30	Falk Pharma Gmbh	Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
FR2792527B1 (fr) *	1999-04-22	2004-08-13	Ethypharm Lab Prod Ethiques	Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques
AU781058B2 (en) *	1999-08-31	2005-05-05	Grunenthal Gmbh	Delayed-action form of administration containing tramadol saccharinate
DE50008261D1 (de) *	1999-08-31	2004-11-18	Gruenenthal Gmbh	Retardierte darreichungsform enthaltend tramadolsaccharinat
WO2001015665A1 (en) *	1999-09-02	2001-03-08	Nostrum Pharmaceuticals, Inc.	Controlled release oral dosage suitable for oral administration
AU2277101A (en)	1999-12-20	2001-07-03	Schering Corporation	Stable extended release oral dosage composition
DE10013029A1 (de) *	2000-03-17	2001-09-20	Roehm Gmbh	Mehrschichtige Arzneiform für die Colonfreigabe
EA200201044A1 (ru) *	2000-03-31	2003-04-24	Нюкомед Аустриа Гмбх	Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин
AR030557A1 (es) *	2000-04-14	2003-08-27	Jagotec Ag	Una tableta en multicapa de liberacion controlada y metodo de tratamiento
KR100477874B1 (ko)	2001-04-10	2005-03-22	곽해수	지방산에스터를 이용한 수용성 철분 미세캡슐
US20050013862A1 (en) *	2001-09-05	2005-01-20	Vectura Limited	Functional powders for oral delivery
WO2003055475A1 (en)	2002-01-03	2003-07-10	Lek Pharmaceutical And Chemical Company D.D.	Controlled release pharmaceutical formulation containing venlafaxine
US20030190355A1 (en) *	2002-04-05	2003-10-09	Hermelin Marc S.	Modified release minerals
DK1894562T3 (da) *	2002-08-15	2011-03-28	Euro Celtique Sa	Farmaceutiske sammensætninger omfattende en opioidantagonist
US6562378B1 (en) *	2002-08-16	2003-05-13	Tsar Health Private Ltd.	Nutritional supplement for adolescents
DE602004028023D1 (de) *	2003-08-29	2010-08-19	Lifecycle Pharma As	Tacrolimus enthaltende feste dispersionen

2005
- 2005-12-01 FR FR0512189A patent/FR2894143B1/fr not_active Expired - Lifetime
2006
- 2006-11-23 WO PCT/FR2006/002577 patent/WO2007063200A1/fr not_active Ceased
- 2006-11-23 PL PL06831163T patent/PL1954251T3/pl unknown
- 2006-11-23 DK DK06831163.8T patent/DK1954251T3/da active
- 2006-11-23 PT PT06831163T patent/PT1954251E/pt unknown
- 2006-11-23 EP EP06831163A patent/EP1954251B1/fr active Active
- 2006-11-23 JP JP2008542790A patent/JP5674275B2/ja active Active
- 2006-11-23 KR KR1020087008548A patent/KR101332744B1/ko active Active
- 2006-11-23 AU AU2006319077A patent/AU2006319077B2/en active Active
- 2006-11-23 RU RU2008126728/15A patent/RU2414211C2/ru active
- 2006-11-23 CA CA2632547A patent/CA2632547C/fr active Active
- 2006-11-23 AT AT06831163T patent/ATE548030T1/de active
- 2006-11-23 ES ES06831163T patent/ES2383760T3/es active Active
- 2006-11-23 US US12/085,501 patent/US8834923B2/en active Active
- 2006-11-23 UA UAA200808585A patent/UA93530C2/ru unknown
- 2006-11-23 NZ NZ566783A patent/NZ566783A/en unknown
- 2006-11-23 BR BRPI0619774-4A patent/BRPI0619774B1/pt active IP Right Grant
- 2006-11-23 SI SI200631341T patent/SI1954251T1/sl unknown
- 2006-11-23 CN CNA2006800453522A patent/CN101321520A/zh active Pending
- 2006-11-23 RS RS20120229A patent/RS52308B/sr unknown
- 2006-11-30 TW TW095144284A patent/TWI374035B/zh active
- 2006-12-01 AR ARP060105306A patent/AR057212A1/es not_active Application Discontinuation
2008
- 2008-02-28 ZA ZA200801896A patent/ZA200801896B/xx unknown
- 2008-03-07 MA MA30732A patent/MA29770B1/fr unknown
- 2008-04-02 TN TNP2008000152A patent/TNSN08152A1/fr unknown
- 2008-04-29 NO NO20082047A patent/NO339720B1/no unknown
- 2008-05-27 IL IL191758A patent/IL191758A/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2632547C (fr)	2014-03-25
FR2894143B1 (fr)	2008-05-02
EP1954251A1 (fr)	2008-08-13
RS52308B (sr)	2012-12-31
SI1954251T1 (sl)	2012-08-31
AU2006319077B2 (en)	2012-03-29
NO20082047L (no)	2008-04-29
KR20080044911A (ko)	2008-05-21
NO339720B1 (no)	2017-01-23
TWI374035B (en)	2012-10-11
BRPI0619774A2 (pt)	2011-10-18
IL191758A (en)	2014-11-30
ATE548030T1 (de)	2012-03-15
AR057212A1 (es)	2007-11-21
KR101332744B1 (ko)	2013-11-25
JP5674275B2 (ja)	2015-02-25
US8834923B2 (en)	2014-09-16
CN101321520A (zh)	2008-12-10
WO2007063200A1 (fr)	2007-06-07
TNSN08152A1 (fr)	2009-10-30
EP1954251B1 (fr)	2012-03-07
JP2009517445A (ja)	2009-04-30
FR2894143A1 (fr)	2007-06-08
RU2414211C2 (ru)	2011-03-20
TW200800303A (en)	2008-01-01
PL1954251T3 (pl)	2012-08-31
IL191758A0 (en)	2008-12-29
AU2006319077A1 (en)	2007-06-07
RU2008126728A (ru)	2010-01-10
US20090162429A1 (en)	2009-06-25
CA2632547A1 (fr)	2007-06-07
MA29770B1 (fr)	2008-09-01
ZA200801896B (en)	2009-09-30
ES2383760T3 (es)	2012-06-26
BRPI0619774B1 (pt)	2021-06-01
NZ566783A (en)	2010-12-24
UA93530C2 (ru)	2011-02-25
PT1954251E (pt)	2012-06-06

Publication	Publication Date	Title
CL2007003049A1 (es)	2008-05-16	Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos.
SI2182949T1 (sl)	2013-10-30	(2S,3R)-N-(2-((3-piridinil)metil)-1-azabiciklo(2.2.2)okt-3-il)benzofuran -2-karboksamid, nove oblike soli in postopki za njihovo uporabo
DK1863812T3 (da)	2010-10-18	Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
BRPI0820665A2 (pt)	2018-05-29	compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos
ZA200902632B (en)	2010-07-28	Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
DK1960352T3 (da)	2013-10-28	2-adamantylurinstof-derivater som selektive 11beta-hsd1 inhibitorer
EP1868628A4 (en)	2009-12-02	COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING POCKET VIRUS INFECTIONS
NO20090628L (no)	2009-04-21	Pyridizinon derivativater
CL2007003100A1 (es)	2008-04-18	Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria.
NO20091395L (no)	2009-04-06	Nye tiofenderivater
WO2009137391A3 (en)	2009-12-30	Benzene sulfonamide thiazole and oxazole compounds
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0816881A2 (pt)	2015-03-17	Composto, composição farmacêutica, uso de um composto, e, métodos para tratar doenças ou distúrbios e para preparar um composto.
DK1760156T3 (da)	2013-03-18	Materialer og fremgangsmåder til effektiv mælkesyrefremstilling
EA200970532A1 (ru)	2009-10-30	Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
DK1670458T3 (da)	2007-04-23	1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika
DK2041069T3 (da)	2012-02-27	Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler
DK2242740T3 (da)	2013-03-25	SF5-derivater som par1-inhibitorer, deres fremstilling og anvendelse som lægemidler
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
IL196136A (en)	2014-11-30	Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses
DK2087890T3 (da)	2014-05-19	Præparat med vedvarende frigørelse til vævsregenereringsterapi
IL190460A0 (en)	2008-11-03	4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
DK2125788T3 (da)	2011-07-11	Heterocykliske forbindelser, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
IL191758A0 (en)	2008-12-29	Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
BRPI0903914A2 (pt)	2015-07-21	Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica.